4//SEC Filing
Kirby Daniel Gordon 4
Accession 0001104659-25-012273
CIK 0001425205other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:17 PM ET
Size
11.1 KB
Accession
0001104659-25-012273
Insider Transaction Report
Form 4
Kirby Daniel Gordon
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2025-02-10+120,000→ 120,000 total→ Common stock (120,000 underlying) - Award
Performance Stock Units
2025-02-10+150,000→ 150,000 total→ Common stock (150,000 underlying) - Award
Stock Options (Right to Buy)
2025-02-10+35,000→ 35,000 totalExercise: $5.32Exp: 2035-02-10→ Common stock (35,000 underlying)
Footnotes (5)
- [F1]Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Each performance stock unit ("PSU") converts into one share of the Issuer's common stock.
- [F4]Up to 150,000 shares of the Issuer's common stock underlying the PSUs may be earned subject to achievement of certain financial milestones.
- [F5]Such earned PSUs shall vest on the date that the Issuer publicly announces its 2025 financial results by filing its Form 10-K with the U.S. Securities and Exchange Commission.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0002055001
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:17 PM ET
- Size
- 11.1 KB